Ignite Creation Date:
2025-12-24 @ 1:09 PM
Ignite Modification Date:
2026-01-21 @ 9:43 PM
Study NCT ID:
NCT05205161
Status:
TERMINATED
Last Update Posted:
2025-01-07
First Post:
2022-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-08-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-17
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-05
First Submit QC Date:
None
Study First Post Date:
2022-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-08-06
Results First Submit QC Date:
None
Results First Post Date:
2025-01-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-19
Last Update Post Date:
2025-01-07
Last Update Post Date Type:
ACTUAL